X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-06-30 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $237.00 | -5,000 | 0 | -100% | -$1,185,000 | |||||
| D | 2021-06-23 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $219.65 | -5,000 | 0 | -100% | -$1,098,250 | |||||
| D | 2021-06-16 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $200.00 | -5,000 | 0 | -100% | -$1,000,000 | |||||
| D | 2021-06-09 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $212.30 | -5,000 | 0 | -100% | -$1,061,500 | |||||
| D | 2021-06-02 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $183.90 | -5,000 | 0 | -100% | -$919,500 | |||||
| D | 2021-05-26 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $168.70 | -5,000 | 0 | -100% | -$843,500 | |||||
| D | 2021-05-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $155.74 | -5,000 | 0 | -100% | -$778,700 | |||||
| D | 2021-05-12 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $154.11 | -5,000 | 0 | -100% | -$770,550 | |||||
| D | 2021-05-10 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $158.48 | -3,670 | 0 | -100% | -$581,617 | |||||
| D | 2021-05-03 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $186.46 | -5,000 | 0 | -100% | -$932,309 | |||||
| D | 2021-04-26 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $175.89 | -5,000 | 0 | -100% | -$879,465 | |||||
| D | 2021-04-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $163.05 | -5,000 | 0 | -100% | -$815,232 | |||||
| D | 2021-04-12 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $138.96 | -5,000 | 0 | -100% | -$694,818 | |||||
| D | 2021-04-05 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $129.71 | -5,000 | 0 | -100% | -$648,530 | |||||
| D | 2021-03-22 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $144.82 | -1,199 | 0 | -100% | -$173,640 | |||||
| D | 2021-03-15 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $140.68 | -10,034 | 0 | -100% | -$1,411,535 | |||||
| D | 2021-03-08 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $128.59 | -16,478 | 0 | -100% | -$2,118,863 | |||||
| D | 2021-03-01 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $150.45 | -10,000 | 0 | -100% | -$1,504,518 | |||||
| D | 2021-02-22 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $164.84 | -5,000 | 0 | -100% | -$824,196 | |||||
| D | 2021-02-08 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $184.56 | -3,670 | 0 | -100% | -$677,319 | |||||
| D | 2021-02-01 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $162.34 | -5,000 | 0 | -100% | -$811,696 | |||||
| D | 2021-01-25 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $143.12 | -5,000 | 0 | -100% | -$715,578 | |||||
| D | 2021-01-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $123.88 | -5,000 | 0 | -100% | -$619,400 | |||||
| D | 2021-01-11 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $117.12 | -5,000 | 0 | -100% | -$585,586 | |||||
| D | 2021-01-04 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $109.33 | -5,000 | 0 | -100% | -$546,626 | |||||
| D | 2020-12-28 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $116.27 | -1,200 | 0 | -100% | -$139,519 | |||||
| D | 2020-12-21 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $142.59 | -17,129 | 0 | -100% | -$2,442,485 | |||||
| D | 2020-12-14 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $157.82 | -25,034 | 0 | -100% | -$3,950,733 | |||||
| D | 2020-12-07 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $158.47 | -20,000 | 0 | -100% | -$3,169,313 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |